Gaithersburg-based Novavax Inc. canceled its highly anticipated annual investors meeting, opting instead to offer promised data on its recently failed RSV vaccine trial during its third quarter earnings call in November. That call will take place Nov. 9, nearly a month after the scheduled investors meeting was scheduled to be held in New York on Tuesday. The delay comes after Novavax (NASDAQ: NVAX) revealed Sept. 15 that the so-called Resolve trial that the so-called Resolve trial of the company's…
from http://www.bizjournals.com/baltimore/news/2016/10/11/following-failed-rsv-trial-novavax-cancels.html?ana=RSS%26s=article_search
via http://baltimorecheckbook.tumblr.com/post/151655431897
No comments:
Post a Comment